J Kramer

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A patient with the classical stigmata of parkinsonism was treated on three separate occasions with levodopa, a combination of levodopa and carbidopa, and lergotrile mesylate, a direct-acting dopamine-receptor agonist. All three treatment regimens resulted in dose-related increases in parkinsonian features. To our knowledge, this response has not been(More)
  • 1